Singapore | 10 March 2023 | News
Digital health anchoring back to reality with slowdown of venture funding in 2022 in APAC
Galen Growth, the leading digital health, data-driven market intelligence company, and FINN Partners, a global...Read more
Pharma | 06 March 2023 | Analysis
The word layoff is accustomed to us and many companies across the globe take part in this exercise. Excuses li...Read more
China | 30 March 2023 | News
New joint venture to commercialise cancer drug toripalimab in 9 Southeast Asian countries
Shanghai Junshi Biosciences Co. and Rxilient Biotech have announced a collaboration on the deve...Read more
Japan | 15 March 2023 | News
Takeda’s dengue vaccine receives first approval in Latin America
Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, ...Read more
New Zealand | 13 March 2023 | News
Breakthrough neurological drug comes from New Zealand to treat Rett Syndrome
A molecule discovered by Distinguished Professor Dame Margaret Brimble of the University of Auckland, New Zeal...Read more
Australia | 31 March 2023 | News
Funding boost for world-first cell transplantation research for nervous system repair in Australia
Australia-based Griffith University’s world-first study into cell transplantation to repair injuries to ...Read more
Korea | 30 March 2023 | News
UK-based PharmaVentures enhances access for South Korean biotechs
PharmaVentures has announced its new office in Korea as part of its continued strategic expansion. Headquarter...Read more
Korea | 29 March 2023 | News
Korea's Seegene to share Syndromic PCR technologies to prevent future pandemics
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, has dec...Read more
Indonesia | 21 March 2023 | News
Indonesian startup Etana secures financing to strengthen oncology portfolio
PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical startup, has secured a new round o...Read more
China | 31 March 2023 | News
Sisram Medical expands footprint in China, acquires PhotonMed for ¥270 M
Israel-based Sisram Medical, a global leading innovator and provider of medical aesthetic devices, has announc...Read more
China | 29 March 2023 | News
Scivita Medical enters into strategic agreement with Boston Scientific in China
Medical technology company Scivita Medical Technology Co. and Boston Scientific have offic...Read more
Singapore | 29 March 2023 | News
Singapore gives nod to first smart wearable stethoscope
Aevice Health, a Singapore-based medtech startup that specialises in developing remote respiratory monitoring ...Read more
Taiwan | 20 March 2023 | News
Taiwan approves new intraocular lens-based surgical implants for use in cataract treatment
AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., have announced...Read more
Korea | 17 March 2023 | News
Korea's Samsung Biologics invests over KRW 1.9 T in new facility
Samsung Biologics, a leading contract development and manufacturing organisation (CDMO) based in South Korea, ...Read more
China | 03 March 2023 | News
Startups in China accelerate development of gene and cell therapy
China-based startups Porton Advanced Solutions and DanausGT Biotechnology have announced a strategic coll...Read more
Singapore | 01 March 2023 | News
GenScript expands footprint in Singapore to provide premium gene synthesis service
GenScript Biotech Corporation has announced the expansion of its Singapore facility to provide a premium gene ...Read more
Australia | 15 February 2023 | News
Groundbreaking trial underway for treatment of advanced Retinitis Pigmentosa in Australia
In collaboration with US-based Kiora Pharmaceuticals, Inc. and The Royal Adelaide Hospital, leading Australian...Read more
A World Sans MALARIA
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people. According to a latest report on malaria from the World Health Organisation (WHO), there were approximately 5.4 million cases and 9000 deaths in the region in 2021. The SEA region has nine countries where malaria is prevalent, and their contribution to the global burden of malaria cases is two per cent. India is the main contributor to the malaria cases in the region, accounting for 82.5 per cent of them, followed by Indonesia with 15.6 per cent, and Myanmar with 1.6 per cent. These three countries were responsible for almost all of the malaria cases in the region, making up 99.7 per cent of the total estimated cases. Governments, healthcare organisations, and communities are implementing innovative strategies, technologies, and programmes that can help curb the spread of malaria. Though these efforts were hampered because of COVID-19, in 2022, the WHO South-East Asia Region renewed its commitment to eliminate malaria by 2030, with countries pledging accelerated action and greater efforts at the sub-national and community levels. Other parts of Asia also progressed well. China was declared Malaria free in June 2021, after 70 years of fighting. In its fights against malaria, Asian countries have recently announced significant investment including a $1.9 million investment in February 2023 by Japan’s GHIT Fund for the research and development of a new malaria drug, and a $1 million contribution by Singapore’s Ministry of Health to the Global Fund to fight AIDS, TB, and Malaria, announced in December 2022. While observing World Malaria day on April 25, let’s explore the current status of Asia’s malaria elimination efforts, highlighting the progress made and strategies needed for a malaria-free future.
For Feedback Email Us: communications@biospectrumasia.com
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
